Skip to main content
OpenTrials

Clinical trial condition

Pneumonia

Explore clinical trials studying Pneumonia. Study availability and eligibility vary by location and protocol.

5,498 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Pneumonia trial results

Completed

LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780268

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • Community Regional Medical Center (Site 203-005), 2823 Fresno Street Fresno, California, United States
  • Keck Hospital of USC (Site 301-020), 1500 San Pablo Street Los Angeles, California, United States
  • UCSF Medical Center at Mount Zion (Site 203-007), 1600 Divisadero St. San Francisco, California, United States
View all 57 locations
View Trial Details
Completed

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780281

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • Southern Arizona VA Healthcare System (Site 074-009), 3601 S. 6th Ave. Tucson, Arizona, United States
  • Community Regional Medical Center (Site 203-005), 2823 Fresno Street Fresno, California, United States
  • VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street Loma Linda, California, United States
View all 105 locations
View Trial Details
Completed

Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection

NCT04818216

Conditions
Acute Kidney Injury, COVID-19, Coronaviridae Infections, +18 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
  • University Health Systems San Antonio, Texas, United States
  • Harborview Medical Center Seattle, Washington, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

NCT04611802

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Alabama Clinical Therapeutics, Llc (Pediatric Site) Birmingham, Alabama, United States
  • Accel Research Sites (Adult Site) Birmingham, Alabama, United States
  • Central Research Associates, Inc (Pediatric Site) Birmingham, Alabama, United States
  • The Pain Center of Arizona (Adult Site) Phoenix, Arizona, United States
View all 154 locations
View Trial Details

Related conditions